Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price is treading water today on fresh acquisition rumours.

Shares in the diverse retailing conglomerate are down 0.4% to $65.33. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) is up 0.4%.

After a quiet start to the year, word on the grapevine is Wesfarmers might be preparing for its next acquisition. If the gossip is true, it could be one of the company's largest deals in many years, trumping the $760 million takeover of Australian Pharmaceutical Industries (API) in 2022.

The rumoured $12 billion target

According to The Australian's Dataroom, Wesfarmers has been evaluating the worthiness of scooping up Ramsay Health Care Ltd (ASX: RHC) for months.

Ramsay Health was founded in 1964 by the late Paul Ramsay. What started as a converted house in Sydney is now a fully-fledged hospital and medical clinic operator spread across 11 countries.

Yet, despite the expansive operations, Ramsay's profits and share price remain unchanged from a decade ago.

Always searching for an opportune buy, Wesfarmers could be eyeing Ramsay as the next gem in its expanding healthcare collection. In 2022, the conglomerate acquired API — the company behind Priceline pharmacies. Last year, Silk Laser Clinics was rolled into the Wesfarmers health division.

Whether 'The Wolf of the West' hopes to eat Ramsay Health whole or pick it apart is unknown at this stage.

Ramsay contains a franchise pharmacy network and 40 in-hospital dispensaries throughout Australia. Furthermore, the company launched an online pharmacy in August last year, which might meld well with Wesfarmers' InstantScripts — a consultation and script-filling telehealth platform — acquisition.

What might be a worry for Wesfarmers shares?

Wesfarmers set an Australian corporate record in 2007 when it acquired Coles Group Ltd (ASX: COL) for $19.3 billion. Back then, Wesfarmers had a market capitalisation of about $40 billion.

Eleven years later, Coles had become a formidable competitor to Woolworths Group Ltd (ASX: WOW). But not without Wesfarmers pouring $8 billion into its turnaround. After all the effort (and money), the conglomerate spun Coles off at a valuation of… $20 billion.

Some argue the Coles escapade was a prime example of opportunity cost.

Ramsay Health is a similarly large candidate. At $16 billion, it's roughly 40% of Wesfarmers' size. More importantly, like Coles, Ramsay could risk dragging Wesfarmers' margins downward.

As shown below, the hospital operator achieved a 1.4% margin for the 12 months ended 31 December 2023. That's a far cry from the nearly 6% the Bunnings-owner is netting.

MeasureWesfarmersRamsay Health Care
Revenue$43.7 billion$16.0 billion
Net profit after tax (NPAT)$2.5 billion$220.5 million
Net margin5.7%1.4%
Forward price-to-earnings (P/E) ratio27.7 times22.4 times
Market capitalisation$74.4 billion$11.7 billion
All financials as of 31 December 2023

The Ramsay Health share price is basking in renewed attention today. At the time of writing, shares are fetching $53.00, up 3.8% from yesterday.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has positions in and has recommended Coles Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Up 116% in a year, Insignia Financial share price rockets again as bidding war heats up

Insignia Financial shares have just attracted takeover interest from a third suitor.

Read more »

Mining workers in high vis vests and hard hats discuss plans for the mining site they are at as heavy equipment moves earth behind them, representing opportunities among ASX 200 shares as nominated by top broker Macquarie
Materials Shares

Fortescue shares charge higher on Red Hawk takeover boost

This mining giant is moving closer to getting a takeover deal over the line.

Read more »

A man in a suit face palms at the downturn happening with shares today.
Mergers & Acquisitions

Guess which $8 billion ASX 200 stock just failed with a takeover bid

It has been an embarrassing outcome for the blue chip stock.

Read more »

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX All Ords tech stock just rocketed 30% on takeover news

The ASX All Ords tech stock is bucking the broader tech sell-off today to rocket higher.

Read more »

a mine worker holds his phone in one hand and a tablet in the other as he stands in front of heavy machinery at a mine site.
Mergers & Acquisitions

Fortescue shares slide on $254m Pilbara acquisition

This mining giant is making a new acquisition. Here's what it has announced.

Read more »

Mergers & Acquisitions

Myer shares race higher on 'overwhelming support' for merger

The department store expects the merger to create a stronger business.

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Insignia Financial shares: When will the bidding war end?

Bidding action for the ASX 200 financial stock continues today.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Mergers & Acquisitions

How Rio Tinto shares could eclipse BHP in 2025, with a little help from Glencore

The financial rumour mill is abuzz about a potential mega merger for Rio Tinto.

Read more »